Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MedAdvisor Limited ( (AU:AHE) ) has issued an announcement.
Adheris Health Limited has disclosed a change in the interests of director Catherine (Kate) Jane Hill following on-market share purchases. Hill acquired 1,500,000 fully paid ordinary shares on 2 March 2026 at an average price of $0.020 per share, increasing her indirect holding via the Dunford Superannuation Fund while maintaining her existing direct shareholding and unlisted options.
Following the transactions, Hill now holds 500,000 fully paid ordinary shares directly, 1,500,000 fully paid ordinary shares indirectly and 1,000,000 unlisted options expiring on 31 December 2031. The move signals increased financial alignment between the director and shareholders, and may be interpreted by the market as a vote of confidence in Adheris Health’s prospects, although no new contracts or changes to director-related agreements were reported.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, associated with MedAdvisor Limited, operates in the healthcare and pharmaceutical technology sector, focusing on patient adherence and engagement solutions. The company leverages digital tools and data-driven services to support medication management and improve health outcomes for patients, working closely with pharmacies, healthcare providers and other stakeholders in the healthcare ecosystem.
Average Trading Volume: 561,398
Technical Sentiment Signal: Sell
Current Market Cap: A$14.01M
For an in-depth examination of AHE stock, go to TipRanks’ Overview page.